These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15166794)

  • 1. LRP5, a multifunctional cell surface receptor.
    Li Y; Bu G
    Curr Opin Lipidol; 2004 Jun; 15(3):361-3. PubMed ID: 15166794
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene targeting approaches in mice: assessing the roles of LRP5 and LRP6 in osteoblasts.
    Zylstra CR; Wan C; VanKoevering KK; Sanders AK; Lindvall C; Clemens TL; Williams BO
    J Musculoskelet Neuronal Interact; 2008; 8(4):291-3. PubMed ID: 19147944
    [No Abstract]   [Full Text] [Related]  

  • 3. [Wnt coreceptor low density lipoprotein receptor related protein 5 (LRP5) mediates the bone formation and glucose induced insulin secretion].
    Sakai J
    Nihon Ronen Igakkai Zasshi; 2004 Nov; 41(6):625-8. PubMed ID: 15651377
    [No Abstract]   [Full Text] [Related]  

  • 4. Lrp5 and bone formation : A serotonin-dependent pathway.
    Yadav VK; Ducy P
    Ann N Y Acad Sci; 2010 Mar; 1192():103-9. PubMed ID: 20392224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin.
    Young JJ; Bromberg-White JL; Zylstra C; Church JT; Boguslawski E; Resau JH; Williams BO; Duesbery NS
    PLoS Pathog; 2007 Mar; 3(3):e27. PubMed ID: 17335347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRP5/6 in Wnt signaling and tumorigenesis.
    Li Y; Bu G
    Future Oncol; 2005 Oct; 1(5):673-81. PubMed ID: 16556044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion.
    Fujino T; Asaba H; Kang MJ; Ikeda Y; Sone H; Takada S; Kim DH; Ioka RX; Ono M; Tomoyori H; Okubo M; Murase T; Kamataki A; Yamamoto J; Magoori K; Takahashi S; Miyamoto Y; Oishi H; Nose M; Okazaki M; Usui S; Imaizumi K; Yanagisawa M; Sakai J; Yamamoto TT
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):229-34. PubMed ID: 12509515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5.
    Wang Z; Shu W; Lu MM; Morrisey EE
    Mol Cell Biol; 2005 Jun; 25(12):5022-30. PubMed ID: 15923619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.
    Rajamannan NM; Subramaniam M; Caira F; Stock SR; Spelsberg TC
    Circulation; 2005 Aug; 112(9 Suppl):I229-34. PubMed ID: 16159822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes.
    Balemans W; Van Hul W
    Endocrinology; 2007 Jun; 148(6):2622-9. PubMed ID: 17395706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass.
    Ferrari SL; Deutsch S; Antonarakis SE
    Curr Opin Lipidol; 2005 Apr; 16(2):207-14. PubMed ID: 15767861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Lrp5 Signaling in Osteoblasts Sensitizes Male Mice to Diet-Induced Disturbances in Glucose Metabolism.
    Kim SP; Frey JL; Li Z; Goh BC; Riddle RC
    Endocrinology; 2017 Nov; 158(11):3805-3816. PubMed ID: 28938444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.
    Balemans W; Devogelaer JP; Cleiren E; Piters E; Caussin E; Van Hul W
    J Bone Miner Res; 2007 May; 22(5):708-16. PubMed ID: 17295608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytic receptor-mediated control of morphogen signaling.
    Willnow TE; Christ A; Hammes A
    Development; 2012 Dec; 139(23):4311-9. PubMed ID: 23132241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
    Gong Y; Slee RB; Fukai N; Rawadi G; Roman-Roman S; Reginato AM; Wang H; Cundy T; Glorieux FH; Lev D; Zacharin M; Oexle K; Marcelino J; Suwairi W; Heeger S; Sabatakos G; Apte S; Adkins WN; Allgrove J; Arslan-Kirchner M; Batch JA; Beighton P; Black GC; Boles RG; Boon LM; Borrone C; Brunner HG; Carle GF; Dallapiccola B; De Paepe A; Floege B; Halfhide ML; Hall B; Hennekam RC; Hirose T; Jans A; Jüppner H; Kim CA; Keppler-Noreuil K; Kohlschuetter A; LaCombe D; Lambert M; Lemyre E; Letteboer T; Peltonen L; Ramesar RS; Romanengo M; Somer H; Steichen-Gersdorf E; Steinmann B; Sullivan B; Superti-Furga A; Swoboda W; van den Boogaard MJ; Van Hul W; Vikkula M; Votruba M; Zabel B; Garcia T; Baron R; Olsen BR; Warman ML;
    Cell; 2001 Nov; 107(4):513-23. PubMed ID: 11719191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.
    Ai M; Holmen SL; Van Hul W; Williams BO; Warman ML
    Mol Cell Biol; 2005 Jun; 25(12):4946-55. PubMed ID: 15923613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.
    Kato M; Patel MS; Levasseur R; Lobov I; Chang BH; Glass DA; Hartmann C; Li L; Hwang TH; Brayton CF; Lang RA; Karsenty G; Chan L
    J Cell Biol; 2002 Apr; 157(2):303-14. PubMed ID: 11956231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.
    Balemans W; Piters E; Cleiren E; Ai M; Van Wesenbeeck L; Warman ML; Van Hul W
    Calcif Tissue Int; 2008 Jun; 82(6):445-53. PubMed ID: 18521528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of bone metabolism by pathogenic mutations and polymorphism in the LRP5-Wnt signaling genes].
    Urano T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():95-100. PubMed ID: 18161089
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of bone formation and vision by LRP5.
    Patel MS; Karsenty G
    N Engl J Med; 2002 May; 346(20):1572-4. PubMed ID: 12015398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.